Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Glucose Clamp Trial Investigating the Biosimilarity of Gan & Lee Insulin Glargine Injection (Insulin Glargine 100 U/mL) With US and EU Lantus® Comparator Products in Patients With Type 1 Diabetes Mellitus

Next Previous
Trial Profile

A Glucose Clamp Trial Investigating the Biosimilarity of Gan & Lee Insulin Glargine Injection (Insulin Glargine 100 U/mL) With US and EU Lantus® Comparator Products in Patients With Type 1 Diabetes Mellitus

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 19 Oct 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin glargine
  • Indications Diabetes mellitus
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Gan&Lee Pharmaceuticals

Most Recent Events

  • 16 Oct 2023 Results presented in a Gan & Lee Pharmaceuticals media release.
  • 13 Oct 2023 According to a Gan & Lee Pharmaceuticals media release, data from this study were presented at the peer-reviewed journal Diabetes, Obesity and Metabolism.
  • 02 Jul 2021 According to a Gan & Lee Pharmaceuticals Co., Ltd media release, the abstract with phase 1 results have recently been published on the journal Diabetes website

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top